U.S. Department of Justice to Sponsor Cellebrite for FedRAMP ATO

TYSONS CORNER, Va., July 23, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the U.S. Department of Justice (DOJ) will serve as the official sponsoring agency for the platform's pursuit of a FedRAMP High authorization.

Cellebrite announced its intent to pursue FedRAMP authorization in 2024. In 2025, Cellebrite Government Cloud (CGC) was reviewed by a Third-Party Assessment Organization (3PAO), and the FedRAMP Program Management Office (PMO) prepared a Readiness Assessment Report (RAR), which granted Cellebrite Government Cloud FedRAMP High Ready status. DOJ’s sponsorship is the critical step required for Cellebrite Government Cloud (CGC) to advance from its current FedRAMP High Ready designation to “In Process” status. This marks a major milestone that significantly accelerates Cellebrite’s compliance journey towards a full Authorization to Operate (ATO).

“We are proud to offer our U.S. federal customers reliable, secure and cutting-edge cloud solutions that enhance their investigative processes and expedite their missions,” said Erik Sachwitz, General Manager of Cellebrite Federal Solutions, Inc. “We are grateful to the Justice Department for entrusting us to implement their workflow on the Cellebrite Government Cloud. This milestone marks a significant advancement to our ongoing efforts to deepen our support of U.S. federal agencies.”

The Cellebrite Government Cloud (CGC) will launch with a comprehensive suite of digital investigative tools. The initial offering provides U.S. federal agencies secure access to two of the company's market-leading solutions: Cellebrite Inseyets, enabling immediate online access to Cellebrite’s latest digital forensics capabilities, and Cellebrite Guardian, for collaborative digital evidence review, sharing and storage. Together, these integrated solutions are designed to deliver greater operational efficiencies, support end-to-end collaboration and strengthen the overall chain of custody to help U.S. federal agencies advance their missions while meeting the scalability and security requirements of national, regional and local public safety customers. By shifting digital investigation workflows to the cloud, agencies and attorneys gain secure, flexible access to evidence from anywhere, while also harnessing advanced analytical capabilities enabled by powerful cloud infrastructure.

Demonstrating a commitment to supporting diverse missions and operational environments, Cellebrite ensures agencies will continue to have access to on-premises, hybrid and fully offline solutions, empowering them to operate effectively regardless of their unique requirements.

References to Websites and Social Media Platforms

References to information included on, or accessible through, websites and social media platforms do not constitute incorporation by reference of the information contained at or available through such websites or social media platforms, and you should not consider such information to be part of this press release.

About Cellebrite

Cellebrite’s (Nasdaq: CLBT) mission is to enable its global customers to protect and save lives by enhancing digital investigations and intelligence gathering to accelerate justice in communities around the world. Cellebrite’s AI-powered Digital Investigation Platform enables customers to lawfully access, collect, analyze and share digital evidence in legally sanctioned investigations while preserving data privacy. Thousands of public safety organizations, intelligence agencies, and businesses rely on Cellebrite’s digital forensic and investigative solutions—available via cloud, on-premises, and hybrid deployments—to close cases faster and safeguard communities. To learn more, visit us at , , and find us on social media @Cellebrite.

Caution Regarding Forward Looking Statements

This document includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward looking statements may be identified by the use of words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “will,” “appear,” “approximate,” “foresee,” “might,” “possible,” “potential,” “believe,” “could,” “predict,” “should,” “could,” “continue,” “expect,” “estimate,” “may,” “plan,” “outlook,” “future” and “project” and other similar expressions that predict, project or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include, but are not limited to, this marks a major milestone that significantly accelerates Cellebrite's compliance journey towards a full Authorization to Operate (ATO); and we are proud to offer our U.S. federal customers reliable, secure and cutting-edge cloud solutions that enhance their investigative processes and expedite their missions are based on current expectations that are subject to risks and uncertainties. A number of factors could cause actual results or outcomes to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to: Cellebrite’s ability to continue advancing its FedRAMP activities to achieve full FedRAMP authorization in a timely manner; Cellebrite’s ability to keep pace with technological advances and evolving industry standards; Cellebrite’s material dependence on the purchase, acceptance and use of its solutions by law enforcement and government agencies; real or perceived errors, failures, defects or bugs in Cellebrite’s DI solutions; Cellebrite’s failure to maintain the productivity of sales and marketing personnel, including relating to hiring, integrating and retaining personnel; intense competition in all of Cellebrite’s markets; the inadvertent or deliberate misuse of Cellebrite’s solutions; failure to manage its growth effectively; Cellebrite’s ability to introduce new solutions and add-ons; Cellebrite’s dependency on its customers renewing their subscriptions and purchasing new subscriptions; the low volume of business Cellebrite conducts via e-commerce; risks associated with the use of artificial intelligence; the risk of requiring additional capital to support the growth of its business; risks associated with Cellebrite’s dependency on third parties for supplying components or services and with higher costs or unavailability of materials used to create its hardware product components; fluctuations in foreign currency exchange rates; lengthy sales cycle for some of Cellebrite’s solutions; near term declines in new or renewed agreements; risks associated with inability to recruit, train and retain qualified personnel and senior management; the security of Cellebrite’s operations and the integrity of its software solutions against cyber-attacks, information technology system breaches or disruptions; risks associated with the negative publicity related to Cellebrite’s business and use of its products; risks related to Cellebrite’s intellectual property; the regulatory constraints to which Cellebrite is subject; risks associated with Cellebrite’s operations in Israel, including the ongoing Israel-Hamas war, the increased tension between Israel and Iran and its proxies, including the ongoing hostilities between Israel and Hezbollah, and the risk of a greater regional conflict; risks associated with different corporate governance requirements applicable to Israeli companies and risks associated with being a foreign private issuer and an emerging growth company; market volatility in the price of Cellebrite’s shares; changing tax laws and regulations; risks associated with joint, ventures, partnerships and strategic initiatives; risks associated with Cellebrite’s significant international operations, including due to fluctuations in foreign currency exchange rates, rising global inflation and exposure to regions subject to political or economic instability; risks associated with Cellebrite’s failure to comply with anti-corruption, trade compliance, anti-money-laundering and economic sanctions laws and regulations; risks relating to the adequacy of Cellebrite’s existing systems, processes, policies, procedures, internal controls and personnel for Cellebrite’s current and future operations and reporting needs; and other factors, risks and uncertainties set forth in the section titled “Risk Factors” in Cellebrite’s annual report on Form 20-F filed with the SEC on March 18, 2025, and in other documents filed by Cellebrite with the U.S. Securities and Exchange Commission (“SEC”), which are available free of charge at . You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, in this communication or elsewhere. Cellebrite undertakes no obligation to update its forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

Media

Victor Cooper

Sr. Director of Corporate Communications + Content Operations

+1 404.510.2823

Investor Relations

Andrew Kramer

Vice President, Investor Relations

+1 973.206.7760